Trial Profile

PHARMACOKINETIC STUDY OF BRAMITOB ADMINISTERED FOR INHALATION BY PARI eFLOW RAPID ELECTRONIC NEBULIZER VS PARI LC PLUS NEBULIZER COUPLED WITH THE PARI TURBO BOY N COMPRESSOR IN CYSTIC FIBROSIS PATIENTS INFECTED WITH PSEUDOMONAS AERUGINOSA.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
16 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
17 Feb 2011 Additional lead trial investigators identified and additional locations identified as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com